Grant: Operating Grant
University of Alberta
$813,550.00
Mitochondrial suppression in pulmonary hypertension
EF 2012-13
Résumé
Disturbance of the way that energy is produced in the cell usually results in disease. There is evidence that disturbance in the energy production in the cells forming the blood vessels of the lungs results in a deadly disease called pulmonary hypertension. In this disease high blood pressure in the lungs results in too much straining of the right chambers of the heart which eventually fail, causing early death. Effective therapies in this disease are urgently needed. Here we plan to investigate how two important components of mitochondria (the energy producers on the cell) can contribute to pulmonary hypertension. We will use animals and human tissues to prove this idea and attempt to develop new therapies for this disease. If successful, we can then try to test them in humans. This is a new approach to this disease that holds promise for novel and effective therapies.
Programme
Operating Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
266953
Name
Michelakis Evangelos D
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Cardiovascular System - C: Vascular System
Projecttitle
Mitochondrial suppression in pulmonary hypertension
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$813,550
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Hypoxia; Metabolism; Mitochondria; Polymorphisms; Pulmonary Hypertension; Vascular Biology
Abstract
Disturbance of the way that energy is produced in the cell usually results in disease. There is evidence that disturbance in the energy production in the cells forming the blood vessels of the lungs results in a deadly disease called pulmonary hypertension. In this disease high blood pressure in the lungs results in too much straining of the right chambers of the heart which eventually fail, causing early death. Effective therapies in this disease are urgently needed. Here we plan to investigate how two important components of mitochondria (the energy producers on the cell) can contribute to pulmonary hypertension. We will use animals and human tissues to prove this idea and attempt to develop new therapies for this disease. If successful, we can then try to test them in humans. This is a new approach to this disease that holds promise for novel and effective therapies.
Competitiondate
201209
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Michelakis, Evangelos D
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $813,550~ $0~